Nevro Corp.

DB:1N7 Stock Report

Market Cap: €162.6m

Nevro Future Growth

Future criteria checks 0/6

Nevro is forecast to grow earnings and revenue by 3.4% and 2.5% per annum respectively. EPS is expected to grow by 5.1% per annum. Return on equity is forecast to be -48.2% in 3 years.

Key information

3.4%

Earnings growth rate

5.1%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate2.5%
Future return on equity-48.2%
Analyst coverage

Good

Last updated12 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:1N7 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026425-80-56-4012
12/31/2025407-96-57-4215
12/31/2024403-89-35-2015
9/30/2024419-69-57-47N/A
6/30/2024426-77-65-56N/A
3/31/2024431-83-71-62N/A
12/31/2023425-92-67-59N/A
9/30/2023423-102-72-63N/A
6/30/202341931322N/A
3/31/202341521524N/A
12/31/202240631725N/A
9/30/2022395-81623N/A
6/30/2022388-140-80-72N/A
3/31/2022386-136-75-63N/A
12/31/2021387-131-54-42N/A
9/30/2021394-108-28-15N/A
6/30/2021409-68112N/A
3/31/2021363-88-80N/A
12/31/2020362-83-51N/A
9/30/2020367-90-29-24N/A
6/30/2020358-98-43-39N/A
3/31/2020396-84-37-34N/A
12/31/2019390-104-54-50N/A
9/30/2019384-100-34-32N/A
6/30/2019379-93-37-34N/A
3/31/2019382-76-25-21N/A
12/31/2018387-49-14-6N/A
9/30/2018377-44-23-13N/A
6/30/2018364-39N/A-2N/A
3/31/2018346-40N/A-7N/A
12/31/2017327-37N/A-14N/A
9/30/2017299-42N/A-27N/A
6/30/2017278-40N/A-35N/A
3/31/2017255-37N/A-42N/A
12/31/2016229-32N/A-59N/A
9/30/2016191-36N/A-73N/A
6/30/2016146-52N/A-101N/A
3/31/2016102-63N/A-114N/A
12/31/201570-67N/A-100N/A
9/30/201546-62N/A-79N/A
6/30/201539-50N/A-57N/A
3/31/201536-38N/A-40N/A
12/31/201433-31N/A-31N/A
9/30/201429-29N/A-27N/A
6/30/201427-26N/A-24N/A
3/31/201425-26N/A-22N/A
12/31/201324-26N/A-21N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1N7 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 1N7 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 1N7 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 1N7's revenue (2.5% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: 1N7's revenue (2.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 1N7 is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y